Clinical TopicsNewsPublic HealthWeb Exclusives

Ozone-depleting inhalers to be phased out

Share

On April 13, the U.S. Food and Drug Administration announced that seven metered-dose inhalers used for asthma and chronic obstructive pulmonary disease will gradually be removed from the market because they contain ozone-depleting cholorofluorocarbons (CFCs). Find more details and the schedule for removal at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm208302.htm.

The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following statements accurately describes hypertrophic cardiomyopathy (HCM)?

More Perspectives